The question isn’t whether costs will rise. It’s whether employers will continue managing around the margins — or address the root cause. The post GLP-1s, Specialty Spend, and a 9% Cost Surge: Why Employers Must Rethink Primary Care Now appeared first on MedCity News.
The truth is there are ways to understand our cancer risk more precisely than we do today, and there are tools to manage it. What’s missing is awareness, access, and a system built to help us use these tools before something goes wrong. The post Why We’re Still Finding Cancer Too Late appeared first on…
Pennsylvania sued Character.ai, alleging one of the startup’s AI chatbots illegally practiced medicine by posing as a licensed psychiatrist. The case marks the second state lawsuit against the startup and highlights growing regulatory scrutiny of AI chatbot platforms and their safety guardrails. The post Pennsylvania Sues Chatbot Over Claims It Impersonates Doctors appeared first on…
Ulcerative colitis is the lead indication for Odyssey Therapeutics’ internally discovered lead drug candidate. With the IPO proceeds, Odyssey plans mid-stage clinical trials evaluating the small molecule in combination with Takeda’s Entyvio and as a monotherapy. The post Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs appeared first on MedCity News.
Practices that embrace automation, interoperability, and consumer-grade payment experiences will reduce risk, strengthen cash flow, and build lasting trust with the patients they serve. Those that delay will continue absorbing avoidable costs and volatility. The post Adapting Healthcare Payments While Facing Financial Pressure and Economic Uncertainty appeared first on MedCity News.
The limitations of general-purpose AI in an emotional support context aren’t what it says. They’re about what it can’t detect, including the markers of acute distress that a purpose-built system is specifically architected to recognize. The post When There’s No Appointment Available, Patients Are Opening ChatGPT appeared first on MedCity News.
Is $50 billion over five years enough to end the rural healthcare crisis or even offset the federal spending cuts? No – but it’s what states have to work with. And the pressure is on them to maximize the impact of their RHTP grants. Here’s how they can do it. The post How States Can…
A new report from Gibbins Advisors showed that healthcare bankruptcy filings rose 33% in the first quarter of 2026, driven mostly by outpatient and senior care providers. At the same time, hospital M&A activity rebounded to its strongest first quarter since early 2020. The post Healthcare Bankruptcies Rise in Q1: 6 Things to Know appeared…
Angelini Pharma’s acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst’s top product is Firdapse, the first FDA-approved drug for a particular rare neuromuscular disorder. The post Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy appeared first on MedCity News.
Patient observation is often misunderstood as simply “watching” a patient, yet its impact extends across patient safety, workforce stability, and clinical flow. In today’s care environments, observation requires trained awareness, consistent documentation, and recognition of subtle changes before escalation occurs. Myth vs. Fact explores common assumptions about patient observation programs and examines how structured approaches translate into real-world safety, workforce…